BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26026128)

  • 1. Impact of stereotactic radiosurgery dose on control of cerebral metastases from renal cell carcinoma.
    Rades D; Huttenlocher S; Gebauer N; Hornung D; Trang NT; Khoa MT; Schild SE
    Anticancer Res; 2015 Jun; 35(6):3571-4. PubMed ID: 26026128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
    Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
    J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.
    Selek U; Chang EL; Hassenbusch SJ; Shiu AS; Lang FF; Allen P; Weinberg J; Sawaya R; Maor MH
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1097-106. PubMed ID: 15234044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery.
    Chang EL; Selek U; Hassenbusch SJ; Maor MH; Allen PK; Mahajan A; Sawaya R; Woo SY
    Neurosurgery; 2005 May; 56(5):936-45; discussion 936-45. PubMed ID: 15854241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two dose levels of stereotactic radiosurgery for 1-3 brain metastases from non-small cell lung cancer.
    Rades D; Huttenlocher S; Dahlke M; Hornung D; Blanck O; Van Thai P; Trang NT; Khoa MT; Schild SE
    Anticancer Res; 2014 Dec; 34(12):7309-13. PubMed ID: 25503165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosurgery alone for 1-3 newly-diagnosed brain metastases from melanoma: impact of dose on treatment outcomes.
    Rades D; Sehmisch L; Huttenlocher S; Blank O; Hornung D; Terheyden P; Gliemroth J; Schild SE
    Anticancer Res; 2014 Sep; 34(9):5079-82. PubMed ID: 25202094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases.
    Lwu S; Goetz P; Monsalves E; Aryaee M; Ebinu J; Laperriere N; Menard C; Chung C; Millar BA; Kulkarni AV; Bernstein M; Zadeh G
    Oncol Rep; 2013 Feb; 29(2):407-12. PubMed ID: 23151681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome of stereotactic radiosurgery for central nervous system metastases from renal cell carcinoma.
    Seastone DJ; Elson P; Garcia JA; Chao ST; Suh JH; Angelov L; Rini BI
    Clin Genitourin Cancer; 2014 Apr; 12(2):111-6. PubMed ID: 24331575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose?
    Rades D; Heisterkamp C; Schild SE
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):398-403. PubMed ID: 20488627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidose stereotactic radiosurgery (9 Gy × 3) of the postoperative resection cavity for treatment of large brain metastases.
    Minniti G; Esposito V; Clarke E; Scaringi C; Lanzetta G; Salvati M; Raco A; Bozzao A; Maurizi Enrici R
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):623-9. PubMed ID: 23683828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome predictors of gamma knife radiosurgery for renal cell carcinoma metastases.
    Kano H; Iyer A; Kondziolka D; Niranjan A; Flickinger JC; Lunsford LD
    Neurosurgery; 2011 Dec; 69(6):1232-9. PubMed ID: 21716155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic radiosurgery plus whole-brain radiotherapy for treatment of multiple metastases from non-small cell lung cancer.
    Minniti G; Salvati M; Muni R; Lanzetta G; Osti MF; Clarke E; Costa A; Bozzao A; Trasimeni G; Enrici RM
    Anticancer Res; 2010 Jul; 30(7):3055-61. PubMed ID: 20683055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyberknife for brain metastases of malignant melanoma and renal cell carcinoma.
    Hara W; Tran P; Li G; Su Z; Puataweepong P; Adler JR; Soltys SG; Chang SD; Gibbs IC
    Neurosurgery; 2009 Feb; 64(2 Suppl):A26-32. PubMed ID: 19165071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.
    Varlotto JM; Flickinger JC; Niranjan A; Bhatnagar A; Kondziolka D; Lunsford LD
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1125-32. PubMed ID: 15990018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic radiosurgery for patients with "radioresistant" brain metastases.
    Brown PD; Brown CA; Pollock BE; Gorman DA; Foote RL
    Neurosurgery; 2002 Sep; 51(3):656-65; discussion 665-7. PubMed ID: 12188943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery.
    Samlowski WE; Majer M; Boucher KM; Shrieve AF; Dechet C; Jensen RL; Shrieve DC
    Cancer; 2008 Nov; 113(9):2539-48. PubMed ID: 18780316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
    Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosurgery for brain metastases from primary lung carcinoma.
    Hoffman R; Sneed PK; McDermott MW; Chang S; Lamborn KR; Park E; Wara WM; Larson DA
    Cancer J; 2001; 7(2):121-31. PubMed ID: 11324765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic radiosurgery without radiation therapy providing high local tumor control of multiple brain metastases from renal cell carcinoma.
    Muacevic A; Kreth FW; Mack A; Tonn JC; Wowra B
    Minim Invasive Neurosurg; 2004 Aug; 47(4):203-8. PubMed ID: 15346315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.